503 related articles for article (PubMed ID: 19383521)
21. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
22. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.
Choi YS; Lee JY; Suh JS; Kwon YM; Lee SJ; Chung JK; Lee DS; Yang VC; Chung CP; Park YJ
Biomaterials; 2010 Feb; 31(6):1429-43. PubMed ID: 19954842
[TBL] [Abstract][Full Text] [Related]
23. The use of cell-penetrating peptides as a tool for gene regulation.
Järver P; Langel U
Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
[TBL] [Abstract][Full Text] [Related]
24. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
Liu B
Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
[TBL] [Abstract][Full Text] [Related]
25. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
26. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
Ma D
Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
[TBL] [Abstract][Full Text] [Related]
27. Polycation gene delivery systems: escape from endosomes to cytosol.
Cho YW; Kim JD; Park K
J Pharm Pharmacol; 2003 Jun; 55(6):721-34. PubMed ID: 12841931
[TBL] [Abstract][Full Text] [Related]
28. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery.
Wang XL; Ramusovic S; Nguyen T; Lu ZR
Bioconjug Chem; 2007; 18(6):2169-77. PubMed ID: 17939730
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
30. Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery.
Wang M; Li X; Ma Y; Gu H
Int J Pharm; 2013 May; 448(1):51-7. PubMed ID: 23524121
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
Xiong XB; Uludağ H; Lavasanifar A
Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
[TBL] [Abstract][Full Text] [Related]
32. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
[TBL] [Abstract][Full Text] [Related]
33. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
[TBL] [Abstract][Full Text] [Related]
34. Barriers to successful delivery of short interfering RNA after systemic administration.
White PJ
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190
[TBL] [Abstract][Full Text] [Related]
35. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
Deshayes S; Morris M; Heitz F; Divita G
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
[TBL] [Abstract][Full Text] [Related]
36. PTD-DRBD siRNA delivery.
Palm-Apergi C; Eguchi A; Dowdy SF
Methods Mol Biol; 2011; 683():339-47. PubMed ID: 21053141
[TBL] [Abstract][Full Text] [Related]
37. Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure.
Tamura A; Oishi M; Nagasaki Y
Biomacromolecules; 2009 Jul; 10(7):1818-27. PubMed ID: 19505137
[TBL] [Abstract][Full Text] [Related]
38. Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates.
Shiraishi T; Nielsen PE
FEBS Lett; 2006 Feb; 580(5):1451-6. PubMed ID: 16460737
[TBL] [Abstract][Full Text] [Related]
39. Functionalization of carbon nanotubes enables non-covalent binding and intracellular delivery of small interfering RNA for efficient knock-down of genes.
Krajcik R; Jung A; Hirsch A; Neuhuber W; Zolk O
Biochem Biophys Res Commun; 2008 May; 369(2):595-602. PubMed ID: 18298946
[TBL] [Abstract][Full Text] [Related]
40. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
Akhtar S
Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1347-62. PubMed ID: 20929276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]